Slimfast Fades as Dieters Turn to Weight Loss Drugs

European Stocks Lifted by Luxury as China Eases Travel Curbs

Novo’s Blockbuster Obesity Drug Still Hit by US Bottlenecks

Novo’s Value Surpasses Denmark GDP After Obesity Drug Boost

Weight-Loss Stocks Soar After Obesity-Drug Study Spurs Investor Frenzy

Obesity Drug Wegovy Cuts Risk of Heart Attacks and Strokes by 20%, Study Shows

Russian warship damaged in Ukrainian attack on Novorossiysk naval base - sources

Dagestan profile

Novo Nordisk weight-loss drug Wegovy launched in Germany, first big EU market

"Last hope": Eager Germans are prepared to pay for weight-loss drug

Lilly to Pay Up to $2 Billion for Obesity Startup Versanis

Strong U.S. demand eases pressure on Novo to show weight-loss drug's health benefits